The Impact on Efficacy and Safety of Patients Receiving Oral Anticoagulant Medication (Warfarin) during the COVID-19 Pandemic

The Impact on Efficacy and Safety of Patients Receiving Oral Anticoagulant Medication (Warfarin) during the COVID-19 Pandemic

Saved in:

Bibliographic Details
Main Authors:	Ubonwan Sapoo, Nuengruthai Phunpha, Patipan Pusopa, Bancha Sookananchai, Chanthaporn Imbumroong, Nilobol Chuemsanthia, Kitiya Muangyot
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2024-07-01
Series:	European Cardiology Review
Online Access:	https://www.ecrjournal.com/articleindex/ecr.2024.19.PO2
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness and Safety of the Coadministration of Rifampin and Warfarin versus Direct Oral Anticoagulants: A Cohort Study
by: Ju-Chieh Wung, et al.
Published: (2024-01-01)

Risk of mortality between warfarin and direct oral anticoagulants: population-based cohort studies
by: Zixuan Wang, et al.
Published: (2024-12-01)

Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin in Cirrhotic Patients: A Systematic Review and Meta-Analysis
by: Chunwei Cheng MD, et al.
Published: (2024-11-01)

Comparing rates of clinically relevant epistaxis in patients taking warfarin versus direct oral anticoagulants
by: Khristian S. Burke, et al.
Published: (2024-11-01)

New warfarin anticoagulation management model after heart valve surgery: rationale and design of a prospective, multicentre, randomised trial to compare an internet-based warfarin anticoagulation management model with the traditional warfarin management model
by: Yan Li, et al.
Published: (2019-12-01)

Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study
by: Ahmed El-Bardissy, et al.
Published: (2025-01-01)

Mechanism of exacerbation of traumatic brain injury under warfarin anticoagulation in male mice.
by: Yuki Tatara, et al.
Published: (2024-01-01)

Prothrombin Complex Concentrate for Rapid Reversal of Warfarin Anticoagulation to Allow Neuraxial Blockade
by: Conor Skerritt, et al.
Published: (2014-01-01)

Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis
by: Guan-lian Mo, et al.
Published: (2025-01-01)

Evaluation of Anticoagulation Control among Patients Taking Warfarin in University of Gondar Hospital, Northwest Ethiopia
by: Zelalem Liyew, et al.
Published: (2021-01-01)

Pharmacodynamic Modeling of Warfarin Dosing Algorithm for Cardiovascular Patients in Indonesia: A Tailored Method to Anticoagulation Therapy
by: Putriana NA, et al.
Published: (2025-01-01)

Comparison of the outcomes of warfarin therapy and economics by online and offline anticoagulation management models: protocol for a randomised controlled trial
by: Xiaotong Xia, et al.
Published: (2019-09-01)

Influence of novel oral anticoagulants on anticoagulation care management
by: Janzic Andrej, et al.
Published: (2017-09-01)

Comparative Investigation of Thromboelastometry and Thrombin Generation for Patients Receiving Direct Oral Anticoagulants or Vitamin K Antagonists
by: Armando Tripodi, et al.
Published: (2024-11-01)

Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation
by: Danial Amoey, et al.
Published: (2024-11-01)

Systemic Embolism and Clinically Significant Bleeding Events in Older Adults with Nonvalvular Atrial Fibrillation After Treatment with Direct Oral Anticoagulants and Warfarin: A Retrospective Cohort Study in Japan
by: Daichi Yaguchi, et al.
Published: (2024-11-01)

Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
by: Defa Huang, et al.
Published: (2024-12-01)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
by: Kimberley Doucette, et al.
Published: (2020-01-01)

Factors related to the choice of warfarin for treating newly diagnosed nonvalvular atrial fibrillation are associated with safety outcomes during anticoagulation: A new‐user, active‐comparator, retrospective cohort study
by: Yoshiko Takagi, et al.
Published: (2024-12-01)

Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation
by: Eva N. Hamulyák, et al.
Published: (2025-02-01)

Regarding re-bleeding and all-cause mortality risk in non-variceal upper gastrointestinal bleeding: focusing on patients receiving oral anticoagulant therapy
by: Muhammed Bahaddin Durak
Published: (2024-12-01)

Safety and efficacy of direct oral anticoagulants in chronic kidney disease: a meta-analysis
by: Daniel Tham, et al.
Published: (2024-10-01)

Direct oral anticoagulants for stroke prevention and risk of bleeding
by: Tomoyuki Kawada
Published: (2025-02-01)

Predictors of direct oral anticoagulant concentrations in the trauma population
by: Laura Adams, et al.
Published: (2024-05-01)

Thrombolysis for ischaemic stroke despite direct oral anticoagulation
by: Ying Xian, et al.

Assessing the knowledge of medical undergraduates on oral anticoagulation therapy
by: Chayna Sarkar, et al.
Published: (2023-09-01)

Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding: a systematic review of randomised clinical trials
by: Christian Ovesen, et al.
Published: (2025-02-01)

Diffuse Alveolar Hemorrhage Associated with Warfarin Therapy
by: Bülent Kaya, et al.
Published: (2015-01-01)

Warfarin-Associated Diaphragmatic Hernia: An Unusual Diagnosis
by: Cristina Vilhena, et al.
Published: (2015-01-01)

Direct Oral Anticoagulants Versus Traditional Anticoagulation in Cirrhotic Patients with Portal Vein Thrombosis: Updated Systematic Review
by: Xiulin Xiao M.S., et al.
Published: (2024-11-01)

Pharmacogenetic substantiation of personalized prescription of oral anticoagulants in clinical practice
by: K.I. Bentsionova, et al.
Published: (2023-03-01)

DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY MAJOR CONGENITAL THROMBOPHILIA
by: alessandra serrao, et al.
Published: (2019-06-01)

Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
by: Mahmoud Abdelnabi, et al.
Published: (2020-02-01)

Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
by: Dana Prídavková, et al.
Published: (2019-01-01)

Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir
by: Ana Pelufo-Pellicer, et al.
Published: (2017-03-01)

Presumptive Haematomyelia Secondary to Warfarin Toxicosis in a Dog
by: Carlos Blanco, et al.
Published: (2022-01-01)

Determining Risk Factors of Bleeding in Patients on Warfarin Treatment
by: Evren Uygungül, et al.
Published: (2014-01-01)

ADVANTAGES AND DISADVANTAGES OF WARFARIN AND PRADAXA THERAPY FOR VENOUS THROMBOEMBOLISM
by: B. S. Sukovatykh, et al.
Published: (2018-01-01)

Risk of development of hemorrhagic complications due to warfarin therapy
by: O. I. Filippova, et al.
Published: (2017-12-01)